NUCLEAR-LOCALIZATION OF THE EPSTEIN-BARR VIRUS/C3D RECEPTOR (CR-2) IN THE HUMAN BURKITT B-LYMPHOMA CELL, RAJI

被引:9
|
作者
GAUFFRE, A
VIRON, A
BAREL, M
HERMANN, J
PUVION, E
FRADE, R
机构
[1] HOP ST ANTOINE, INSERM, U354, UNITE IMMUNOCHIM REGULAT CELLULAIRES & INTERACT VI, F-75571 PARIS 12, FRANCE
[2] CNRS, UPR 272, INST RECH SCI CANC, F-94801 VILLEJUIF, FRANCE
基金
澳大利亚研究理事会;
关键词
D O I
10.1016/0161-5890(92)90044-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epstein-Barr virus/C3d receptor (CR2) is a glycoprotein of mol. wt 140,000 expressed on the surface of Raji cells. We previously isolated phosphorylated CR2 from purified Raji cell nuclei. We have analyzed the nuclear localization of CR2 by electron microscope immunochemistry of thin sections of Raji cells and we have compared the binding properties of CR2 expressed on purified plasma membranes or nuclei. Anti-CR2 mAb immunogold labeling of thin sections of Raji cells identified CR2 at the nuclear surface and also within the nucleus. Nuclear envelope associated CR2 was localized mainly at nuclear pores. Within the nucleus, CR2 was associated with ribonucleoprotein (RNP) interchromatin fibrils. This labeling was preserved in nuclear matrix preparations. CR2 expressed on the surfaces of purified nuclei or on the cell surface interacted with soluble and particle-bound C3bi/C3d. Monoclonal anti-CR2 antibodies, which recognized extracellular domains of CR2, reacted differently with CR2 depending on its subcellular localization. The presence of CR2 in nuclei may be due to translocation of the cell surface CR2 and/or the presence of two distinct intracellular pathways for mature CR2.
引用
收藏
页码:1113 / 1120
页数:8
相关论文
共 50 条
  • [41] Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection
    1600, American Society for Biochemistry and Molecular Biology Inc., Bethesda, United States (265):
  • [42] Evidence for a new transcript of the Epstein-Barr virus C3d receptor (CR2, CD21) which is due to alternative exon usage
    Barel, M
    Balbo, M
    Frade, R
    MOLECULAR IMMUNOLOGY, 1998, 35 (16) : 1025 - 1031
  • [43] STRUCTURE AND FUNCTIONS OF GP-140, THE C3D/EBV RECEPTOR (CR-2) OF HUMAN LYMPHOCYTES-B
    FRADE, R
    MOLECULAR IMMUNOLOGY, 1986, 23 (11) : 1249 - 1253
  • [44] A COMPLEMENT RECEPTOR LOCUS - GENES ENCODING C3B/C4B RECEPTOR AND C3D/EPSTEIN-BARR VIRUS RECEPTOR MAP TO 1Q32
    WEIS, JH
    MORTON, CC
    BRUNS, GAP
    WEIS, JJ
    KLICKSTEIN, LB
    WONG, WW
    FEARON, DT
    JOURNAL OF IMMUNOLOGY, 1987, 138 (01): : 312 - 315
  • [45] Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression
    Takakuwa, T
    Luo, WJ
    Ham, MF
    Sakane-Ishikawa, F
    Wada, N
    Aozasa, K
    AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (03): : 967 - 974
  • [46] EPSTEIN-BARR VIRUS COMPLEMENT FRAGMENT C3D RECEPTOR (CR-2) REACTS WITH P53, A CELLULAR ANTIONCOGENE-ENCODED MEMBRANE PHOSPHOPROTEIN - DETECTION BY POLYCLONAL ANTI-IDIOTYPIC ANTI-CR2 ANTIBODIES
    BAREL, M
    FIANDINO, A
    LYAMANI, F
    FRADE, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 10054 - 10058
  • [47] PRODUCTION OF INFECTIVE EPSTEIN-BARR VIRUS IN A BURKITT LYMPHOMA CELL LINE, P3HR-1
    NAGOYA, T
    HINUMA, Y
    GANN, 1972, 63 (01): : 87 - &
  • [48] EXPRESSION OF CR-2 (C3D RECEPTOR) ON THE CELL-MEMBRANES OF ADULT T-CELL LEUKEMIA
    KAI, C
    OKADA, N
    OKADA, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1988, 79 (07): : 805 - 808
  • [49] EXPRESSION OF CR-1 AND CR-2 COMPLEMENT RECEPTORS FOLLOWING EPSTEIN-BARR VIRUS-INFECTION OF BURKITTS-LYMPHOMA CELL-LINES
    COHEN, JHM
    FISCHER, E
    KAZATCHKINE, MD
    LENOIR, GM
    LEFEVREDELVINCOURT, C
    REVILLARD, JP
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 25 (06) : 587 - 598
  • [50] Role of Epstein-Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma
    Mabuchi, Seiyo
    Hijioka, Fumiya
    Watanabe, Takahiro
    Yanagi, Yusuke
    Okuno, Yusuke
    Al Masud, H. M. Abdullah
    Sato, Yoshitaka
    Murata, Takayuki
    Kimura, Hiroshi
    CANCERS, 2021, 13 (03) : 1 - 16